NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Romix Biosciences

Romix Biosciences

Private
Ithaca, New YorkHealthcare & Life Scienceshttps://romixbio.com/

Last Round

Pre Seed

Jul 30, 2025

Total Funding Raised

$1.34M

Company Overview

Romix Biosciences is a biotechnology company that develops an AI-enabled, full-body molecular scan platform using cell-free RNA liquid biopsy for disease profiling and drug development.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting, Usage-Based SaaS

AI Layer

Application

Keywords

cell-free RNAcfRNAliquid biopsymolecular diagnosticsprecision medicinedisease profilingbiomarker discoverypatient stratificationdrug developmentbiofluid analysisAI-enabled diagnosticsmulti-omicsbiotech platformclinical research

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Romix Biosciences Comparables

Compare Romix Biosciences with similar companies based on industry and business-model similarity.

Romix Biosciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

Romix Biosciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Pre SeedJul 30, 2025
AcceleratorOct 29, 2024
AcceleratorAug 1, 2024

Key People

Founding team and executive leadership

David McKellar

CTO Co-founder

Founding Team

Conor Loy

Chief Executive Officer

Executive Team

Romix Biosciences Investors

Notable investors and investment history

Romix Biosciences investors
InvestorRounds
First Star VenturesPre Seed
2048 VenturesPre Seed

Romix Biosciences Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Romix Biosciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Romix Biosciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersIthaca, New York
Employee Range7
Year Founded2024
Last FundingJul 30, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.